The most used diabetes medications were metformin (95.0%), followed by sodium-glucose transport protein 2 (SGLT2) inhibitors (82.5%), sulfonylureas (47.5%), and dipeptidyl peptidase-4 (DPP-4) inhibitors (40.0%). Here, SLC5A2 is linked to diabetes mellitus.